home / stock / ate:cc / ate:cc news


ATE:CC News and Press, Antibe Therapeutics Inc.

Stock Information

Company Name: Antibe Therapeutics Inc.
Stock Symbol: ATE:CC
Market: TSXC
Website: antibethera.com

Menu

ATE:CC ATE:CC Quote ATE:CC Short ATE:CC News ATE:CC Articles ATE:CC Message Board
Get ATE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

ATE:CC - Antibe Announces Appointment of Receiver

Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE) announced that the Company’s request for an extension of its previously announced stay of proceedings under the Companies’ Creditors Arrangement Act (the “ CCAA ”...

ATE:CC - Antibe Provides Update on CCAA Proceedings

Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE) announced that the Company sought an extension of its previously announced stay of proceedings (“ Stay ”) under the Companies’ Creditors Arrangement Act (the “ ...

ATE:CC - Antibe Announces TSX Delisting Review

Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE) announced that the Toronto Stock Exchange (“TSX”) is reviewing the eligibility for continued listing on the TSX of the securities of the Company. The TSX has identified the Compan...

ATE:CC - Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE, OTCQX: ATBPF) announced that its previously announced application for an Initial Order under the Companies' Creditors Arrangement Act (the " CCAA "), has been granted by the Ontario Sup...

ATE:CC - Canadian Investment Regulatory Organization Trade Resumption - ATE

Canadian Investment Regulatory Organization Trade Resumption - ATE Canada NewsWire VANCOUVER, BC , April 9, 2024 /CNW/ - Trading resumes in: Company: Antibe Therapeutics Inc. TSX-Venture Symbol: ATE All Issues: Yes Resumption (ET): 9:15 AM CIR...

ATE:CC - Canadian Investment Regulatory Organization Trading Halt - ATE

Canadian Investment Regulatory Organization Trading Halt - ATE Canada NewsWire TORONTO , April 9, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Antibe Therapeutics Inc. TSX Symbol: ATE All Issues: Yes Reason: Dissemination H...

ATE:CC - Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the Ontario Superior Court of Justice (Commercial List) (the " Court ") for an Initial Order under the Companies'...

ATE:CC - Canadian Companies Moving the Markets, Evening edition
Mon, Apr 01, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada Argonaut Gold Inc. (AR) fell 1.3% to $0.385 on volume of 16,325,009 shares Toronto-Dominion Bank (The) (TD) rose 0.2% to $81.88 on volume of 14,586,024 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) rose 10.2% to $3.77 on volume of 13...

ATE:CC - Canadian Companies Moving the Markets, Morning edition
Mon, Apr 01, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada iShares ESG Aware MSCI Emerging Markets Index ETF (XSEM) rose 0.9% to $19.37 on volume of 5,016,270 shares Argonaut Gold Inc. (AR) rose 1.3% to $0.395 on volume of 3,197,941 shares B2Gold Corp. (BTO) rose 0.8% to $3.58 on volume of 2,715,774 sha...

ATE:CC - Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration (“FDA”) that otenaproxesul has been placed on clinical...

Next 10